Application of magnetically induced hyperthermia on the model protozoan Crithidia fasciculata as a potential therapy against parasitic infections
V. Graz\'u, A.M. Silber, M. Moros, L. As\'in, T.E. Torres, C., Marquina, M.R. Ibarra, G.F. Goya

TL;DR
This study demonstrates that magnetic hyperthermia using Fe3O4 nanoparticles can selectively induce death in protozoan parasites like Crithidia fasciculata, suggesting a novel therapeutic approach against parasitic infections.
Contribution
First application of magnetic hyperthermia to protozoan parasites, showing its potential as a targeted therapy with minimal toxicity and no temperature rise in the medium.
Findings
Magnetic nanoparticles were effectively incorporated by protozoa without toxicity.
Application of TVMF induced massive, non-apoptotic cell death in MNP-loaded protozoa.
No temperature increase was observed during hyperthermia treatment.
Abstract
Magnetic hyperthermia is currently an EU-approved clinical therapy against tumor cells that uses magnetic nanoparticles under a time varying magnetic field (TVMF). The same basic principle seems promising against trypanosomatids causing Chagas disease and sleeping sickness, since therapeutic drugs available display severe side effects and drug-resistant strains. However, no applications of this strategy against protozoan-induced diseases have been reported so far. In the present study, Crithidia fasciculata, a widely used model for therapeutic strategies against pathogenic trypanosomatids, was targeted with Fe_{3}O_{4} magnetic nanoparticles (MNPs) in order to remotely provoke cell death using TVMFs. The MNPs with average sizes of d approx. 30 nm were synthesized using a precipitation of FeSO_{4}4 in basic medium. The MNPs were added to Crithidia fasciculata choanomastigotes in…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
